Back to top

NRIX Maintained by Morgan Stanley -- Price Target Raised to $38

NRIX Maintained by Morgan Stanley -- Price Target Raised to $38

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nurix Therapeutics, Inc. (NRIX)